MAPSW experienced a dramatic collapse in operating profitability with operating income falling to under $1 million from nearly $15 million in the prior year.
The company's core business profitability has deteriorated severely, with operating income declining by over 90% despite maintaining a solid cash position. This suggests fundamental operational challenges that extend beyond typical market volatility, particularly concerning given the company's position in the evolving cannabis technology sector.
MAPSW's financial performance shows a stark divergence between profitability and balance sheet strength. While operating income collapsed to less than $1 million and net income declined substantially, the company maintained healthy liquidity with cash growing to $62.4 million and stockholders' equity expanding 58.5% to $57.2 million. Operating cash flow declined 28.6% to $26.2 million, indicating underlying operational stress despite the strong balance sheet position.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Net income declined 74.3% — review whether driven by operations, interest costs, or non-recurring items.
Equity base grew 58.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Receivables surged 45.3% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
R&D spending cut 22.8% — could signal cost discipline or concerning reduction in innovation investment.
Current assets grew 22.2% — improving short-term liquidity or inventory/receivables build.
Cash grew 20.1% — improving liquidity position supports investment and shareholder returns.
Current liabilities rose 19.1% — increased short-term obligations, watch current ratio.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →